Laborleiter der Arbeitsgruppe Lungenforschung, Deutsches Zentrum für Lungenforschung (DZL), MHH: ‘COVID-19 – Regenerative Angiogenesis in Lungs and Hearts’ Prof. Dr. Armin Braun, Division Director Preclinical [...] repurposing as a novel approach in drug development using the example of inhalative therapy against Covid-19’ 14.07.2021 - REBIRTH Kolloquium (1 pm s.t., online Vorträge) Prof Dr. Claudia Grothe, Institut
ncbi.nlm.nih.gov/34992256/ . Ackermann M, Jonigk DD. Microvascular placental alterations in maternal COVID-19. Am J Obstet Gynecol. 2022;226:135-136. https://pubmed.ncbi.nlm.nih.gov/34228972/ . Ackermann M [...] C, Bodey AJ, Bellier A, Verleden SE, Lee PD, Mentzer SJ, Jonigk DD. The bronchial circulation in COVID-19 pneumonia. Am J Respir Crit Care Med. 2022;205:121-125. https://pubmed.ncbi.nlm.nih.gov/34734553/ [...] Welte T, Seeliger B, David S, Schuppan D, Mentzer SJ, Jonigk DD. The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling. EBioMedicine. 2022;85:104296.
Zasada E, Schmitz M, Quabach RA, Hrincheva M, Fühner T, Kielstein JT. Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry. Nephrol Dial Transplant
Österreich. 07/2022 The interaction of active and passive ignorance in the science communication on COVID-19. Symposium Kukla, Q R: Science Communication, Public Opinion, and the Epistemology of Ignorance
Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID-19. Eur J Immunol. 2024 Nov;54(11):e2451236. doi: 10.1002/eji.202451236. Epub 2024 Oct 14. PMID: 39402787 [...] analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine. EBioMedicine. 2024 Jan;99:104947. doi: 10.1016/j.ebiom.2023.104947. Epub 2023 Dec 30. [...] Förster, R. (2023). Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals. Frontiers in immunology, 14, 1166589. https://doi.org/10.3389/fimmu.2023
It is intended to pave the way for a European Health Union, contribute to the recovery after the COVID-19 crisis and make healthcare systems more resilient. Further information on the health programme
responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19. Nat Commun. 2022 Aug 18;13(1):4872. doi: 10.1038/s41467-022-32527-2. PMID: 35982040; PMCID: PMC9387891 [...] Cornberg M, Koenecke C, Behrens GMN, Bošnjak B, Förster R. Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment [...] Schulz TF, Förster R. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods. Cell Mol Immunol. 2020 Nov 2:1–9
generational change in senior positions and advocated for the further development of the university. The COVID-19 pandemic posed a particular challenge, requiring major organisational and scientific adjustments [...] against the pandemic, for example by developing new test strategies, conducting clinical research on COVID-19 and organising the vaccination campaign. Despite these adversities, he succeeded in further developing
Seuchter SA, Kapsner LA; our MII research group. Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data. Strahlenther Onkol. 2022 Apr;198(4):334-345. doi:10
semesters and is normally only allowed for a maximum of two consecutive semesters. Covid-19 : Specific circumstances due to Covid-19 can be mentioned manually with a proof (e.g. no childcare options). Students